Encompass Health (EHC) Ratios
Encompass Health Ratios
MX:EHC's free cash flow for Q3 2026 was $127.50M. For the 2026 fiscal year, MX:EHC's free cash flow was decreased by $-234.50M and operating cash flow was $362.00M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.08 | 1.05 | 1.28 | 1.25 | 1.23 |
| Quick Ratio | 1.08 | 1.05 | 1.28 | 1.25 | 1.23 |
| Cash Ratio | 0.12 | 0.10 | 0.16 | 0.04 | 0.07 |
| Solvency Ratio | 0.23 | 0.20 | 0.16 | 0.14 | 0.14 |
| Operating Cash Flow Ratio | 1.41 | 1.19 | 1.30 | 1.23 | 0.96 |
| Short-Term Operating Cash Flow Coverage | 16.77 | 8.73 | 17.40 | 28.01 | 38.28 |
| Net Current Asset Value | $ -2.91B | $ -2.80B | $ -2.96B | $ -3.06B | $ -3.54B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.38 | 0.42 | 0.48 | 0.53 | 0.51 |
| Debt-to-Equity Ratio | 1.11 | 1.31 | 1.78 | 2.28 | 1.82 |
| Debt-to-Capital Ratio | 0.53 | 0.57 | 0.64 | 0.70 | 0.65 |
| Long-Term Debt-to-Capital Ratio | 0.47 | 0.50 | 0.59 | 0.68 | 0.60 |
| Financial Leverage Ratio | 2.91 | 3.16 | 3.70 | 4.30 | 3.59 |
| Debt Service Coverage Ratio | 6.27 | 4.11 | 4.54 | 3.83 | 4.30 |
| Interest Coverage Ratio | 8.55 | 6.29 | 12.02 | 3.59 | 4.01 |
| Debt to Market Cap | 0.21 | 0.24 | 0.36 | 0.47 | 0.56 |
| Interest Debt Per Share | 28.23 | 28.54 | 30.92 | 31.94 | 36.83 |
| Net Debt to EBITDA | 1.86 | 2.22 | 2.81 | 3.41 | 3.86 |
| Profitability Margins | |||||
| Gross Profit Margin | 43.22% | 41.56% | 41.30% | 40.32% | 42.43% |
| EBIT Margin | 18.13% | 16.51% | 15.24% | 14.41% | 16.67% |
| EBITDA Margin | 23.66% | 22.08% | 20.95% | 20.01% | 22.14% |
| Operating Profit Margin | 17.74% | 16.09% | 35.92% | 14.49% | 16.42% |
| Pretax Profit Margin | 16.06% | 13.95% | 12.65% | 10.37% | 12.58% |
| Net Profit Margin | 9.54% | 8.48% | 7.33% | 6.23% | 10.27% |
| Continuous Operations Profit Margin | 12.81% | 11.16% | 9.89% | 8.06% | 10.04% |
| Net Income Per EBT | 59.41% | 60.79% | 57.97% | 60.12% | 81.62% |
| EBT Per EBIT | 90.49% | 86.71% | 35.20% | 71.53% | 76.58% |
| Return on Assets (ROA) | 7.99% | 6.97% | 5.77% | 4.81% | 6.00% |
| Return on Equity (ROE) | 23.22% | 22.05% | 21.37% | 20.68% | 21.57% |
| Return on Capital Employed (ROCE) | 16.84% | 15.18% | 31.67% | 12.45% | 10.78% |
| Return on Invested Capital (ROIC) | 13.28% | 11.80% | 24.56% | 9.59% | 8.52% |
| Return on Tangible Assets | 10.36% | 9.20% | 7.75% | 6.62% | 7.54% |
| Earnings Yield | 5.31% | 4.94% | 5.30% | 4.57% | 8.02% |
| Efficiency Ratios | |||||
| Receivables Turnover | 9.59 | 8.97 | 7.85 | 8.10 | 8.00 |
| Payables Turnover | 18.91 | 18.36 | 16.58 | 19.53 | 17.25 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 1.38 | 1.40 | 1.37 | 1.38 | 1.45 |
| Asset Turnover | 0.84 | 0.82 | 0.79 | 0.77 | 0.58 |
| Working Capital Turnover Ratio | 102.86 | 46.46 | 29.39 | 27.71 | 19.88 |
| Cash Conversion Cycle | 18.78 | 20.80 | 24.48 | 26.37 | 24.49 |
| Days of Sales Outstanding | 38.08 | 40.68 | 46.50 | 45.06 | 45.65 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 19.30 | 19.88 | 22.02 | 18.69 | 21.16 |
| Operating Cycle | 38.08 | 40.68 | 46.50 | 45.06 | 45.65 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 11.70 | 10.04 | 8.55 | 7.11 | 7.23 |
| Free Cash Flow Per Share | 4.37 | 3.61 | 2.69 | 1.23 | 1.66 |
| Dividend Paid and CapEx Coverage Ratio | 1.46 | 1.42 | 1.32 | 1.03 | 1.08 |
| Capital Expenditure Coverage Ratio | 1.60 | 1.56 | 1.46 | 1.21 | 1.30 |
| Operating Cash Flow Coverage Ratio | 0.43 | 0.37 | 0.29 | 0.24 | 0.21 |
| Operating Cash Flow to Sales Ratio | 0.20 | 0.19 | 0.18 | 0.16 | 0.18 |
| Free Cash Flow Yield | 4.12% | 3.91% | 4.03% | 2.05% | 3.20% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 18.89 | 20.39 | 18.86 | 21.89 | 12.46 |
| Price-to-Sales (P/S) Ratio | 1.80 | 1.72 | 1.38 | 1.36 | 1.28 |
| Price-to-Book (P/B) Ratio | 4.37 | 4.46 | 4.03 | 4.53 | 2.69 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 24.29 | 25.61 | 24.80 | 48.75 | 31.21 |
| Price-to-Operating Cash Flow Ratio | 9.07 | 9.20 | 7.80 | 8.41 | 7.18 |
| Price-to-Earnings Growth (PEG) Ratio | 0.78 | 0.73 | 0.63 | -0.64 | 0.28 |
| Enterprise Value Multiple | 9.46 | 9.99 | 9.41 | 10.23 | 9.64 |
| Enterprise Value | 13.28B | 11.85B | 9.47B | 8.90B | 8.57B |
| EV to EBITDA | 9.46 | 9.99 | 9.41 | 10.23 | 9.64 |
| EV to Sales | 2.24 | 2.21 | 1.97 | 2.05 | 2.13 |
| EV to Free Cash Flow | 30.23 | 32.90 | 35.37 | 73.16 | 52.06 |
| EV to Operating Cash Flow | 11.29 | 11.82 | 11.13 | 12.61 | 11.97 |
| Tangible Book Value Per Share | 16.42 | 12.69 | 7.41 | 3.19 | 10.14 |
| Shareholders’ Equity Per Share | 24.26 | 20.69 | 16.56 | 13.21 | 19.31 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.20 | 0.20 | 0.22 | 0.22 | 0.20 |
| Revenue Per Share | 59.06 | 53.79 | 48.25 | 43.84 | 40.55 |
| Net Income Per Share | 5.63 | 4.56 | 3.54 | 2.73 | 4.16 |
| Tax Burden | 0.59 | 0.61 | 0.58 | 0.60 | 0.82 |
| Interest Burden | 0.89 | 0.85 | 0.83 | 0.72 | 0.75 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.05 | 0.05 | 0.04 | 0.05 | 0.06 |
| Stock-Based Compensation to Revenue | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 |
| Income Quality | 2.07 | 1.67 | 2.35 | 1.93 | 1.38 |
Currency in USD